跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
兆珂速 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Daratumumab Injection (Subcutaneous Injection)
Approved
生物制品
Daratumumab Injection (Subcutaneous Injection)
Janssen-Cilag International NV
🇨🇳 National Medical Products Administration
Approval Date
Sep 30, 2021
Approval ID
8BYszLsjihe
Company
Janssen-Cilag International NV
Type
生物制品
Approval Details
Approval Id
8BYszLsjihe
Approval Number
国药准字SJ20210025
Generic Name
达雷妥尤单抗注射液(皮下注射)
Generic Name En
Daratumumab Injection (Subcutaneous Injection)
Trade Name
兆珂速
Drug Type
生物制品
Dosage Form
注射剂
Strength
1800mg（15ml）/瓶
Reg Date
2021-09-30
Expired Date
2026-09-29
Company Name
Janssen-Cilag International NV
Production Company Name
Cilag AG
Company Detail Path
/organization/janssen-cilag-international-nv
Production Company Detail Path
/organization/cilag-ag
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Sep 30, 2021
Approval ID
8BYszLsjihe
Type
生物制品
Back to NMPA Approvals
